Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Janus Kinase Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
TOFACITINIB	155,647	7,847	5.0%	21,976	4,957	57.6 yrs	81.6%
RUXOLITINIB	68,133	10,908	16.0%	14,461	1,288	59.7 yrs	48.8%
UPADACITINIB	65,656	2,406	3.7%	15,931	636	57.4 yrs	71.2%
BARICITINIB	8,108	717	8.8%	2,498	477	58.2 yrs	67.9%
ABROCITINIB	3,170	57	1.8%	329	49	48.5 yrs	53.9%
PACRITINIB	2,563	292	11.4%	455	2	71.8 yrs	45.1%

Head-to-Head Comparisons

TOFACITINIB vs RUXOLITINIB TOFACITINIB vs UPADACITINIB TOFACITINIB vs BARICITINIB TOFACITINIB vs ABROCITINIB RUXOLITINIB vs UPADACITINIB RUXOLITINIB vs BARICITINIB RUXOLITINIB vs ABROCITINIB UPADACITINIB vs BARICITINIB UPADACITINIB vs ABROCITINIB BARICITINIB vs ABROCITINIB

← Back to Janus Kinase Inhibitors [MoA] Class side effects →